ACE2 and TMPRSS2 not only mediate SARS‐CoV‐2 infection may also be involved in cancer progression (such as affecting tumor proliferation, matastasis or immune infiltration), and they can be used as targets to treat cancer patients infected with SARS‐CoV‐2. This evidence concerns the gene TMPRSS2 and neoplasm.